Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Deep-Well Microplates

By Drug Discovery Trends Editor | August 15, 2012

Deep-well polypropylene microplates from Porvair Sciences are shown in a new applications report to contain almost no significant levels of leachable or extractable compounds which might affect the integrity of stored samples.

The report shows the result of GC/MS analysis carried out by Porvair Sciences on a wide range of different manufacturers’ polypropylene deep well plates to establish levels of extractable or leachable contaminants in each of them.  While the Porvair plates showed no significant contaminants many of the deep well plates from alternative sources showed  contaminating peaks from chemicals used in the polypropylene to assist the injection moulding process.

Manufactured under class 10,000 conditions from ultra-pure grade polypropylene, Porvair deep well plates contain no contaminants that may leach out and affect stored samples or cell growth.  For sensitive biological applications – Porvair offers a selection of deep well plates that are available certified as RNase / DNase free.  Available in a choice of formats, volumes and well shapes – Porvair deep well plates are precisely manufactured to SBS/ANSI dimensions ensuring complete compatibility with microplate washers and automated equipment.

Porvair Sciences

The report shows the result of GC/MS analysis carried out by Porvair Sciences on a wide range of different manufacturers’ polypropylene deep well plates to establish levels of extractable or leachable contaminants in each of them.  While the Porvair plates showed no significant contaminants many of the deep well plates from alternative sources showed  contaminating peaks from chemicals used in the polypropylene to assist the injection moulding process.

Manufactured under class 10,000 conditions from ultra-pure grade polypropylene, Porvair deep well plates contain no contaminants that may leach out and affect stored samples or cell growth.  For sensitive biological applications – Porvair offers a selection of deep well plates that are available certified as RNase / DNase free.  Available in a choice of formats, volumes and well shapes – Porvair deep well plates are precisely manufactured to SBS/ANSI dimensions ensuring complete compatibility with microplate washers and automated equipment.

Porvair Sciences


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE